Literature DB >> 28012597

Cervical spine disorders and its association with tinnitus: The "triple" hypothesis.

Federica Bressi1, Manuele Casale2, Rocco Papalia3, Antonio Moffa4, Alberto Di Martino3, Sandra Miccinilli1, Fabrizio Salvinelli4, Vincenzo Denaro3, Silvia Sterzi1.   

Abstract

Subjective tinnitus and cervical spine disorders (CSD) are among the most common complaints encountered by physicians. Although the relationship between tinnitus and CSD has attracted great interest during the past several years, the pathogenesis of tinnitus induced by CSD remains unclear. Conceivably, CSD could trigger a somatosensory pathway-induced disinhibition of dorsal cochlear nucleus (DCN) activity in the auditory pathway; furthermore, CSD can cause inner ear blood impairment induced by vertebral arteries hemodynamic alterations and trigeminal irritation. In genetically -predisposed CSD patients with reduced serotoninergic tone, signals from chronically stimulated DCNs could activate specific cortical neuronal networks and plastic neural changes resulting in tinnitus. Therefore, an early specific tailored CSD treatments and/or boosting serotoninergic activity may be required to prevent the creation of 'tinnitus memory circuits' in CSD patients.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28012597     DOI: 10.1016/j.mehy.2016.11.003

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  Effectiveness of Dry Needling in Bothersome Chronic Tinnitus in Patients with Myofascial Trigger Points.

Authors:  Carla Alexandra Campagna; Juliana Anauate; Laura Garcia E Vasconœlos; Jeanne Oiticica
Journal:  Int Arch Otorhinolaryngol       Date:  2021-08-30

2.  Comparison of the effectiveness between transcutaneous electrical nerve stimulation, manual acupuncture, and electroacupuncture on tinnitus: study protocol for a randomized controlled trial.

Authors:  Young-Kyun Moon; Min Hee Kim; Hae Jeong Nam
Journal:  Trials       Date:  2018-06-27       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.